Cushing Patrick R, Fellows Abigail, Villone Daniel, Boisguérin Prisca, Madden Dean R
Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.
Biochemistry. 2008 Sep 23;47(38):10084-98. doi: 10.1021/bi8003928. Epub 2008 Aug 29.
The cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial chloride channel mutated in patients with cystic fibrosis. Its expression and functional interactions in the apical membrane are regulated by several PDZ (PSD-95, discs large, zonula occludens-1) proteins, which mediate protein-protein interactions, typically by binding C-terminal recognition motifs. In particular, the CFTR-associated ligand (CAL) limits cell-surface levels of the most common disease-associated mutant DeltaF508-CFTR. CAL also mediates degradation of wild-type CFTR, targeting it to lysosomes following endocytosis. Nevertheless, wild-type CFTR survives numerous cycles of uptake and recycling. In doing so, how does it repeatedly avoid CAL-mediated degradation? One mechanism may involve competition between CAL and other PDZ proteins including Na (+)/H (+) exchanger-3 regulatory factors 1 and 2 (NHERF1 and NHERF2), which functionally stabilize cell-surface CFTR. Thus, to understand the biochemical basis of WT-CFTR persistence, we need to know the relative affinities of these partners. However, no quantitative binding data are available for CAL or the individual NHERF2 PDZ domains, and published estimates for the NHERF1 PDZ domains conflict. Here we demonstrate that the affinity of the CAL PDZ domain for the CFTR C-terminus is much weaker than those of NHERF1 and NHERF2 domains, enabling wild-type CFTR to avoid premature entrapment in the lysosomal pathway. At the same time, CAL's affinity is evidently sufficient to capture and degrade more rapidly cycling mutants, such as DeltaF508-CFTR. The relatively weak affinity of the CAL:CFTR interaction may provide a pharmacological window for stabilizing rescued DeltaF508-CFTR in patients with cystic fibrosis.
囊性纤维化跨膜传导调节因子(CFTR)是一种上皮细胞氯离子通道,在囊性纤维化患者中发生突变。它在顶端膜中的表达和功能相互作用受几种PDZ(PSD-95、盘状大蛋白、紧密连接蛋白-1)蛋白调节,这些蛋白通常通过结合C末端识别基序介导蛋白质-蛋白质相互作用。特别是,CFTR相关配体(CAL)限制了最常见的疾病相关突变体DeltaF508-CFTR的细胞表面水平。CAL还介导野生型CFTR的降解,使其在胞吞作用后靶向溶酶体。然而,野生型CFTR在多次摄取和再循环过程中存活下来。在这个过程中,它是如何反复避免CAL介导的降解的呢?一种机制可能涉及CAL与其他PDZ蛋白之间的竞争,包括钠(+)/氢(+)交换体-3调节因子1和2(NHERF1和NHERF2),它们在功能上稳定细胞表面的CFTR。因此,为了理解野生型CFTR持续存在的生化基础,我们需要了解这些伙伴的相对亲和力。然而,目前尚无关于CAL或单个NHERF2 PDZ结构域的定量结合数据,并且已发表的NHERF1 PDZ结构域的估计值相互矛盾。在这里,我们证明CAL PDZ结构域对CFTR C末端的亲和力远低于NHERF1和NHERF2结构域,从而使野生型CFTR能够避免过早陷入溶酶体途径。同时,CAL的亲和力显然足以捕获并更快地降解循环更快的突变体,如DeltaF508-CFTR。CAL与CFTR相互作用的相对较弱亲和力可能为稳定囊性纤维化患者中挽救的DeltaF508-CFTR提供一个药理学窗口。